{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "I93M",
          "position": "93"
        },
        "variant_string_id": "UCH-L1 I93M"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper describes a study on UCH-L1, a protein associated with Parkinson's disease. The aim is to investigate the unconventional secretion of UCH-L1 and its potential involvement in Parkinson's disease pathology.",
          "judgment": "Yes",
          "judgment_basis": "Explicit statements about the disease's molecular basis and how the gene/protein functions within it are present."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "",
          "judgment": "Yes",
          "judgment_basis": "The paper uses a functional assay (investigating unconventional secretion) that reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not explicitly stated but can be inferred based on experimental design."
                }
              ],
              "judgment": "Yes"
            },
            {
              "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field)? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 3c: Variant Controls",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were known benign variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4a: Statistical Analyses",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
              "questions": [
                {
                  "question": "Internal Information: Extract the OddsPath value calculated in the paper for this variant. If a direct OddsPath is not given but robust statistics are, infer the strength.",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            }
          ]
        }
      ],
      "overall_conclusion": "The paper provides functional evidence that suggests the I93M variant of UCH-L1 may be pathogenic based on its impact on the unconventional secretion of UCH-L1. However, more data is needed to calculate OddsPath or apply PS3/BS3 criteria."
    },
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "Mutant_X (not specified in the text)",
          "position": "(not provided)"
        },
        "variant_string_id": "UCH-L1 Mutant_X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper describes a study on UCH-L1, a protein associated with Parkinson's disease. The aim is to investigate the unconventional secretion of UCH-L1 and its potential involvement in Parkinson's disease pathology.",
          "judgment": "Yes",
          "judgment_basis": "Explicit statements about the disease's molecular basis and how the gene/protein functions within it are present."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "",
          "judgment": "Yes",
          "judgment_basis": "The paper uses a functional assay (investigating unconventional secretion) that reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not explicitly stated but can be inferred based on experimental design."
                }
              ],
              "judgment": "Yes"
            },
            {
              "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field)? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 3c: Variant Controls",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were known benign variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4a: Statistical Analyses",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient)",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            },
            {
              "sub_step_name": "Sub-step 4c: Correlate OddsPath (if statistical analyses were sufficient)",
              "questions": [
                {
                  "question": "Internal Information: Extract the OddsPath value calculated in the paper for this variant. If a direct OddsPath is not given but robust statistics are, infer the strength.",
                  "answer": ""
                }
              ],
              "judgment": "Not applicable"
            }
          ]
        }
      ],
      "overall_conclusion": "The paper provides functional evidence that suggests the unspecified mutant variant of UCH-L1 may be pathogenic based on its impact on the unconventional secretion of UCH-L1. However, more data is needed to calculate OddsPath or apply PS3/BS3 criteria."
    }
  ]
}